Correlation Between Valneva SE and Neurobo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Valneva SE and Neurobo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Valneva SE and Neurobo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Valneva SE ADR and Neurobo Pharmaceuticals, you can compare the effects of market volatilities on Valneva SE and Neurobo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Valneva SE with a short position of Neurobo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Valneva SE and Neurobo Pharmaceuticals.
Diversification Opportunities for Valneva SE and Neurobo Pharmaceuticals
0.84 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Valneva and Neurobo is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Valneva SE ADR and Neurobo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurobo Pharmaceuticals and Valneva SE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Valneva SE ADR are associated (or correlated) with Neurobo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurobo Pharmaceuticals has no effect on the direction of Valneva SE i.e., Valneva SE and Neurobo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Valneva SE and Neurobo Pharmaceuticals
Given the investment horizon of 90 days Valneva SE ADR is expected to under-perform the Neurobo Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Valneva SE ADR is 1.52 times less risky than Neurobo Pharmaceuticals. The stock trades about -0.41 of its potential returns per unit of risk. The Neurobo Pharmaceuticals is currently generating about -0.15 of returns per unit of risk over similar time horizon. If you would invest 283.00 in Neurobo Pharmaceuticals on August 24, 2024 and sell it today you would lose (43.00) from holding Neurobo Pharmaceuticals or give up 15.19% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 95.65% |
| Values | Daily Returns |
Valneva SE ADR vs. Neurobo Pharmaceuticals
Performance |
| Timeline |
| Valneva SE ADR |
| Neurobo Pharmaceuticals |
Valneva SE and Neurobo Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Valneva SE and Neurobo Pharmaceuticals
The main advantage of trading using opposite Valneva SE and Neurobo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Valneva SE position performs unexpectedly, Neurobo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurobo Pharmaceuticals will offset losses from the drop in Neurobo Pharmaceuticals' long position.| Valneva SE vs. Lyra Therapeutics | Valneva SE vs. Hookipa Pharma | Valneva SE vs. Cingulate Warrants | Valneva SE vs. SAB Biotherapeutics |
| Neurobo Pharmaceuticals vs. Allarity Therapeutics | Neurobo Pharmaceuticals vs. Virax Biolabs Group | Neurobo Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Neurobo Pharmaceuticals vs. Biodexa Pharmaceticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |